Alumis (ALMS) Non-Current Assets (2023 - 2025)
Alumis (ALMS) reported Non-Current Assets of $93.7 million for Q4 2025, up 169.24% year-over-year from $34.8 million in Q4 2024, and down 1.07% quarter-over-quarter from $94.7 million in Q3 2025.
Alumis (ALMS) Non-Current Assets (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Non-Current Assets data on file, last reported at $93.7 million in Q4 2025.
- Non-Current Assets for Q4 2025 came in at $93.7 million, up 169.24% year-over-year; the trailing twelve-month figure through Dec 2025 was $317.6 million (up 116.63% YoY), and the FY2025 annual result was $93.7 million, up 169.24% from the prior year.
- Non-Current Assets declined to $93.7 million in Q4 2025 per ALMS's latest filing, from $94.7 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $94.7 million in Q3 2025 and troughed at $34.8 million in Q4 2024.
- A 3-year average of $58.0 million and a median of $38.3 million in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets dropped 4.0% in 2024, then jumped 169.24% in 2025.
- A 3-year view of Non-Current Assets shows it stood at $36.3 million in 2023, then decreased by 4.0% to $34.8 million in 2024, then jumped by 169.24% to $93.7 million in 2025.
- Business Quant data shows ALMS's Non-Current Assets at $93.7 million in Q4 2025, $94.7 million in Q3 2025, and $93.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 93.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 93.71 Mn |
| Sep 30, 2025 | 94.72 Mn |
| Jun 30, 2025 | 93.37 Mn |
| Mar 31, 2025 | 35.77 Mn |
| Dec 31, 2024 | 34.80 Mn |
| Sep 30, 2024 | 35.21 Mn |
| Jun 30, 2024 | 40.32 Mn |
| Dec 31, 2023 | 36.26 Mn |